Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep201 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Evaluation of the prevalence phenotypic criteria of GLIM on hospitalized patients in a third-level hospital: a cross-sectional study

Mola Reyes Laura , Maria Garcia Moreno Rosa , Llaro Mary , Minon Sanchez Gonzalo , Lopez Plaza Bricia , Palma Milla Samara

Rationale: The Global Leadership Initiative on Malnutrition (GLIM) criteria was recently proposed as the world’s first diagnostic criteria for malnutrition in adults in hospital settings. The GLIM approach is based on the assessment of three phenotypic and two etiologic criteria, with diagnosis confirmed by any combination of one phenotypic and one etiologic criterion fulfilled. The purpose of this study was to evaluate the prevalence phenotypic criteria of GLIM in hospit...

ea0081ep197 | Calcium and Bone | ECE2022

Correlation between vitamin D levels and severity of COVID 19 disease. Argentine Experience

Garcia Maria Laura , Lisdero Ana Paula , Giacoia Evangelina , Lopez Franco , Cruceno Mauro , Pollini Valeria , Esposito Marcia , Scarabino Mariana , Bacigaluppi Susana , Mumbach Aizhar Giselle

Objective Vitamin D (VD) plays a role in immune response. Recent data shows that low levels of VD could worsen COVID-19 outcomes. This study aimed to establish an association between VD levels among COVID-19 patients with clinical outcomes and inflammatory markers.Methods Prospective multicentric cohort study. Consecutively recruitment. Patients were grouped according admission status and level of VD [sufficient >30 ng/ml (VDS), insufficient 20–...

ea0090p657 | Endocrine-related Cancer | ECE2023

Novel insights to study the potential of the somatostatin system in NETs and NECs

Mangili Federica , Trinidad Moreno Montilla Maria , Garcia Vioque Victor , Pedraza-Arevalo Sergio , Blazquez Encinas Rey Ricardo , Mantovani Giovanna , Peverelli Erika , Schrader Joerg , Ibanez Costa Alejandro , Castano Justo P.

Neuroendocrine tumors (NETs) and carcinomas (NECs) are a heterogeneous group of malignances whose incidence is increasing worldwide. First-line approach is represented by surgery, whereas an effective pharmacological treatment for disseminated and relapsing disease is still needed. Somatostatin (SS) receptors (SSTs) constitute the main suitable pharmacological targets for NETs therapy with SS analogs (SSAs). Nevertheless, a large proportion of NETs and most NECs, are unrespons...

ea0090ep599 | Endocrine-related Cancer | ECE2023

Treatment with 177Lu-dotatate in metastasic advanced neuroendocrine tumors with positive expression of somatostatin receptors, in a third level hospital in Spain from 2015–2022

Giron Giselle , Hernandez Lorena , ISABEL DEL OLMO GARCIA MARIA , Camara-Gomez Rosa , Bello Pilar , Prado Stephan , Segura Angel , Francisco Merino Torres Juan

Introduction: 177Lu-Oxodotreotide(PRRT-Lu) has the approval by EMA and FDA since 2017 for the treatment of patients with gastro-entero-pancreatic neuroendocrine tumors(GEP-NET). However, in daily clinical practice it has also been used in other NET tumors such as paragangliomas, lung NET, medullary thyroid cancer, and others. The aim of this study is to describe the characteristics and follow-up of patients treated with PRRT-Lu in a third level hospital in Spain fro...

ea0066oc4.3 | Oral Communications 4 | BSPED2019

Defects in LGR4 Wnt-β-catenin signalling impair GnRH network development, leading to delayed puberty

Mancini Alessandra , Howard Sasha R , Cabrera Claudia P , Barnes Michael R , David Alessia , Wehkalampi Karoliina , Vassert Gilbert , Cariboni Anna , Garcia Maria Isabelle , Guasti Leonardo , Dunkel Leo

Background: The initiation of puberty is heralded by increasing gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus. During embryonic life the GnRH neuroendocrine network develops thanks to a coordinated migration of neurons from the nasal placode to the forebrain. Our group has previously demonstrated that dysregulation in GnRH neuronal migration leads to delayed pubertal onset. Late puberty affects up to 2% of the population and is associated with adverse h...

ea0063gp183 | Benign Thyroid Disorders | ECE2019

High-dose intravenous levothyroxine treatment as a successful, safe and clinically effective therapy option in severe hypothyroidism: a retrospective study

Aznar Pablo Trincado , Garcia Maria Martinez , Sanchez Beatriz Lardies , Alaminos Maria Elena Lopez , Fernandez Mikel Gonzalez , Rosas Karol Almendra Alvarado , Lacleta Isabel Melchor , Perez Javier Acha

Introduction: Treatment of hypothyroidism with levothyroxine is effective and simple; however, international guidelines advise starting with low doses in case of severe hypothyroidism, cardiac illness and aged population. Interestingly, and in contradiction to this dogma, high doses of levothyroxine have been given to patients with myxedema coma without untoward effects. The difference between myxedema coma, which deserves an intensive treatment, and longstanding severe hypoth...

ea0063p959 | Diabetes, Obesity and Metabolism 3 | ECE2019

Different pattern of clinical presentation between newly onset ketone prone diabetes and type 1 diabetes in a tertiary hospital

Martinez Garcia Maria , Elena Lopez Alaminos Maria , Trincado Aznar Pablo , Gonzalez Fernandez Mikel , Alvarado Rosas Almendra , Sanz Paris Alejandro , Acha Perez Javier

Introduction: A new subtype of diabetes, ketosis-prone diabetes (KPD) has been described in the last years among African, Asian and Hispanic population with characteristics similar to type 1 diabetes (DM1) such as cardinal symptoms, tendency to ketosis and decreased pancreatic reserve at onset, but with negative autoimmunity. The aim of this study was to compare this type of patients with those with type 1 diabetes at onset and their evolution.Material a...

ea0063p1224 | Thyroid 3 | ECE2019

Skin fistula after sorafenib use in differentiated thyroid cancer

Alaminos Maria Elena Lopez , Garcia Maria Martinez , Aznar Pablo Trincado , Fernandez Mikel Gonzalez , Rosas Karol Almendra Alvarado , Paris Alejandro Sanz , Perez Javier Acha

Introduction: Papillary thyroid cancer (PTC) has an excellent prognosis in most cases with a 10-year survival rate of more than 95% but decreases drastically in cases of PTC iodine-refractory, in recurrent and/or metastatic disease. Tyrosine kinase inhibitors, such as lenvatinib or sorafenib, have been approved in such cases and in some cases are able to stabilize the disease and prolong survival. However, serious side effects have been reported such as fistula formation, blee...

ea0063p1225 | Thyroid 3 | ECE2019

Clinical picture and etiology of severe hypothyroidism in a tertiary hospital setting: Implications for clinical practice

Aznar Pablo Trincado , Alaminos Maria Elena Lopez , Sanchez Beatriz Lardies , Garcia Maria Martinez , Fernandez Leticia Perez , de Castro Hernandez Paloma , Callau Francisco Losfablos , Ruiz Maria Luisa Gracia

Introduction: Myxedema coma is a rare life-threatening clinical condition in patients with longstanding severe untreated hypothyroidism, in whom adaptive mechanisms fail to maintain homeostasis. Most patients, however, are not comatose, and, although strict criteria have been proposed, it is often difficult to differentiate it from very severe hypothyroidism, lacking only a precipitating event.Material and methods: We present the clinical picture of 70 c...

ea0063p1227 | Thyroid 3 | ECE2019

Beneficial and fast impact of intravenous levothyroxine therapy on the lipid profile in severe hypothyroid patients

Aznar Pablo Trincado , Garcia Maria Martinez , Sanchez Beatriz Lardies , Alaminos Maria Elena Lopez , Rosas Almendra Alvarado , Monreal Isabel Azcona , Garcia Patricia de Diego , Zapata Adiego Concepcion

Introduction: Abnormalities of lipid metabolism and arterial hypertension occur with increased frequency in hypothyroidism and are associated with a higher risk of premature atherosclerotic vascular disease. Therefore, a vigorous lipid lowering treatment seems mandatory, including quickly restoration of thyroid function, to reduce vascular risk. We evaluate benefits on lipid profile after intravenous thyroxine treatment in severe hypothyroid patients at three and thirty days.<...